During its Q1 call, Elekta indicated that H1 would be weaker than H2, and we believe this is reflected by consensus. For Q2, we forecast sales growth of c-5% YOY and organic growth of c-1% YOY. We expect order intake of cSEK4.9bn, broadly in line with consensus, and that the book-to-bill in Q2 should remain well above 1x. We are still cautious regarding Elekta’s longer-term performance, and reiterate our HOLD, while we have lowered our target price to SEK69 (76).
The Q3 results were mixed, with German governance issues clouding an otherwise solid performance. Now excluding the prohibited Norwegian Vitec acquisition combined with the German project business challenges, we have cut our 2024–2026e EPS by 3–10% and our target price to SEK37 (39). We reiterate our BUY, still seeing solid potential for a ‘buy-and-build’ sector roll-up case in the fragmented European UIM service market.
Our Q3 survey of the US shale universe showed limited revisions to guidance for 2024, and we still expect muted 2024 production growth of ~4–5% YOY (+8% YOY in 2023). Our survey also suggests capex down ~2% YOY, as the companies continue to guide for flat activity. Limited colour was provided on 2025 activity levels and associated capex, which we will know more about in the Q4 results season. For Q3, our universe marginally underspent its cash flow, albeit with net debt continuing to build QOQ a...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Aker BP ASA and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 8 November 2024 in which we reassessed the appropriateness of the ratings in the context of the...
Year to date, Aker BP’s stock has been the weakest among the European majors and North Sea large caps, down ~25%. This is despite operational tailwinds: raised production guidance; lowered cost guidance; projects commencing production ahead of schedule and below budget; and a positive trend in the Johan Sverdrup plateau commentary. Thus, although the post-Q4 share price performance has tended to be lacklustre over the past five years, we believe a lot of negatives are priced in, and see some ups...
This week, DNO reported Q3 underlying results fairly in line with our estimates. It also introduced a long-term production guidance for its North Sea operations, which we find a bit too aggressive. Still, we estimate the North Sea net production to increase from 15kboed in 2024 to >20kboed in 2027. In other news, Equinor acquired a 11.8% stake from Sval Energi in the Halten East development, and BlueNord’s preliminary October production figures were at the lower end of its Q4 base production gui...
A director at Tomra Systems ASA bought 3,000 shares at 157.672NOK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
This week, Aker BP reported Q3 results, with underlying figures in line with expectations. We believe operational tailwinds could benefit it going into 2025, with consensus perhaps underestimating the production potential. Meanwhile, although OKEA reported a strong Q3, we believe it was overshadowed by the introduction of production and capex guidance, which we consider soft. In other news, we see several potential share-price catalysts for BlueNord in the coming months, with the Tyra restart se...
AUCTUS PUBLICATIONS ________________________________________ Condor Energies (CDR CN)C; Target price of C$5.80 per share: Another positive operating update – The work-overs of two new existing wells have added 441 boe/d after a combined 20 m of previously unperforated reservoir pay was accessed. The first well is producing 410 boe/d. It was previously shut-in. The second well is producing an extra 31 boe/d (+65%) and continues to clean-up. With a total cost of 100 wells on Condor’s fields includ...
>EBITDA 5% above forecasts but EBIT and NI impacted by impairments - Aker BP has published its Q3 2024 results with EBITDA 5% above forecasts. That said, EBIT came in 10% below forecasts at $ 1.7bn (-26% q-o-q) and net income was 60% below forecasts at $ 173m, due to the booking of $ 304m in technical impairments, which are relatively frequent at the group. The second piece of good news was the increase in CFFO from $ 1.45bn to $ 2.8bn which benefited from fewer tax ...
>Un EBITDA 5% supérieur aux attentes mais EBIT et NI impactés par les impairements - Aker BP a publié ses résultats du T3 2024 avec un EBITDA 5% supérieur aux attentes. Toutefois, l‘EBIT est ressorti 10% inférieur aux attentes à 1.7 Md$ (-266% QoQ) et le résultat net 60% inférieur à 173 M$ à cause des impairements techniques de 304 M$ assez fréquents chez le groupe. La deuxième bonne nouvelle est la hausse du CFFO de 1.45 Md$ à 2.8 Md$ qui bénéficie de moins de décai...
We consider the underlying Q3 results in line, with a solid FCF beat helped by working capital release. Due to solid performance from the drilled wells put into production at Johan Sverdrup YTD, the field is now likely to produce at plateau “well into 2025” (previously “early 2025”). We believe Aker BP could benefit from operational tailwinds into 2025, with consensus possibly underestimating the production potential. We reiterate our BUY and NOK280 target price.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.